GSK Plans $100M Mont. Vaccine Production Site Expansion
GlaxoSmithKline PLC is investing $100 million to expand its vaccine manufacturing site in Montana to increase production capacity, including for its new shingles vaccine, the pharmaceutical giant said Wednesday....To view the full article, register now.
Already a subscriber? Click here to view full article